The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Cardiovascular Abnormalities in Sickle Cell Disease
Open accessAbstract
Sickle cell disease is characterized by recurrent episodes of ischemia-reperfusion injury to multiple vital organ systems and a chronic hemolytic anemia, both contributing to progressive organ dysfunction. The introduction of treatments that induce protective fetal hemoglobin and reduce infectious complications has greatly prolonged survival. However, with increased longevity, cardiovascular complications are increasingly evident, with the notable development of a progressive proliferative systemic vasculopathy, pulmonary hypertension (PH) and left ventricular diastolic dysfunction. Pulmonary hypertension is reported in autopsy studies and numerous clinical studies have shown that increased pulmonary pressures are an important risk marker for mortality in these patients. In epidemiological studies, the development of PH is associated with intravascular hemolysis, cutaneous leg ulceration, renal insufficiency, iron overload and liver dysfunction. Chronic anemia in sickle cell disease results in cardiac chamber dilation and a compensatory increase in left ventricular mass. This is often accompanied by left ventricular diastolic dysfunction which has also been a strong independent predictor of mortality patients with sickle cell disease. Both PH and diastolic dysfunction are associated with marked abnormalities in exercise capacity in these patients. Sudden death is an increasingly recognized problem and further cardiac investigations are necessary to recognize and treat high-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Rudski, L. G., Lai, W. W., Afilalo, J., Hua, L., Handschumacher, M. D., Chandrasekaran, K., Solomon, S. D., Louie, E. K., & Schiller, N. B. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.05.010 · Cited by 7,049
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelisa, A. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep007 · Cited by 3,351 · cited 1×
“Although a tissue Doppler-derived E/e’ ratio 15 is accepted as a predictor of high LV filling pressure in the setting of LV dysfunction, the application of this in patients with preserved systolic function has been difficult (73).”
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 3×
“inhibits hemoglobin S polymerization) (10).”
InfluentialRees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Self-citationSildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Wall stress and patterns of hypertrophy in the human left ventricle.
Grossman, W., Jones, D., & McLaurin, L. P. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108079 · Cited by 2,403
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Self-citationPathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Self-citationMorris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 763
Sitaxsentan Therapy for Pulmonary Arterial Hypertension
Barst, R. J., Langleben, D., Frost, A., Horn, E. M., Oudiz, R., Shapiro, S., McLaughlin, V., Hill, N., Tapson, V. F., Robbins, I. M., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-957oc · Cited by 706
Kato, G. J., McGowan, V., Machado, R. F., Little, J. A., Taylor, J., Morris, C. R., Nichols, J. S., Wang, X., Poljakovic, M., Morris, S. M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2373 · Cited by 661
Self-citationDaily Assessment of Pain in Adults with Sickle Cell Disease
Smith, W. R., Penberthy, L. T., Bovbjerg, V. E., McClish, D. K., Roberts, J. D., Dahman, B., Aisiku, I. P., Levenson, J. L., & Roseff, S. D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-2-200801150-00004 · Cited by 648
Management of Sickle Cell Disease
Steinberg, M. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401307 · Cited by 604
Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
Kirk, P., Roughton, M., Porter, J. B., Walker, J. M., Tanner, M. A., Patel, J., Wu, D., Taylor, J., Westwood, M. A., Anderson, L. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.874487 · Cited by 597
Donadee, C., Raat, N. J. H., Kanias, T., Tejero, J., Lee, J. S., Kelley, E. E., Zhao, X., Liu, C., Reynolds, H., Azarov, I., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.008698 · Cited by 572
Self-citationKasner, M., Westermann, D., Steendijk, P., Gaub, R., Wilkenshoff, U., Weitmann, K., Hoffmann, W., Poller, W., Schultheiss, H.-P., Pauschinger, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.661983 · Cited by 565
Lewis, G. D., Shah, R., Shahzad, K., Camuso, J. M., Pappagianopoulos, P. P., Hung, J., Tawakol, A., Gerszten, R. E., Systrom, D. M., Bloch, K. D., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.716373 · Cited by 515
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005565 · Cited by 512
Pulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470
Self-citationMortality in Sickle Cell Disease
(1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311515 · Cited by 459
Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Voskaridou, E., Christoulas, D., Bilalis, A., Plata, E., Varvagiannis, K., Stamatopoulos, G., Sinopoulou, K., Balassopoulou, A., Loukopoulos, D., & Terpos, E. (2010) · Blood · doi:10.1182/blood-2009-05-221333 · Cited by 430
Cardiovascular effects of anemia
Varat, M. A., Adolph, R. J., & Fowler, N. O. (1972) · American Heart Journal · doi:10.1016/0002-8703(72)90445-0 · Cited by 429
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
Kaul, D. K., & Hebbel, R. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9225 · Cited by 417
Belcher, J. D., Marker, P. H., Weber, J. P., Hebbel, R. P., & Vercellotti, G. M. (2000) · Blood · doi:10.1182/blood.v96.7.2451 · Cited by 367
Iron-Chelating Therapy for Transfusional Iron Overload
Brittenham, G. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1004810 · Cited by 366
Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure
Lewis, G. D., Lachmann, J., Camuso, J., Lepore, J. J., Shin, J., Martinovic, M. E., Systrom, D. M., Bloch, K. D., & Semigran, M. J. (2007) · Circulation · doi:10.1161/circulationaha.106.626226 · Cited by 353
Causes of death in sickle cell disease: an autopsy study
Manci, E. A., Culberson, D. E., Yang, Y., Gardner, T. M., Powell, R., Haynes, J., Shah, A. K., Mankad, V. N., & Investigators of the Cooperative Study of Sickle Cell Disease (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04594.x · Cited by 350
Kato, G. J., Hebbel, R. P., Steinberg, M. H., & Gladwin, M. T. (2009) · American Journal of Hematology · doi:10.1002/ajh.21475 · Cited by 349
Self-citationMyocardial iron loading in transfusion-dependent thalassemia and sickle cell disease
Wood, J. C., Tyszka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2004) · Blood · doi:10.1182/blood-2003-06-1919 · Cited by 341
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Castro, O., Hoque, M., & Brown, B. D. (2003) · Blood · doi:10.1182/blood-2002-03-0948 · Cited by 327
Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease
Sachdev, V., Machado, R. F., Shizukuda, Y., Rao, Y. N., Sidenko, S., Ernst, I., St. Peter, M., Coles, W. A., Rosing, D. R., Blackwelder, W. C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.038 · Cited by 323
Self-citationPulmonary hypertension in patients with sickle cell disease: a longitudinal study
Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06110.x · Cited by 298
Sickle cell anemia as an inflammatory disease
Platt, O. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10726 · Cited by 293
Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease
Lanzkron, S., Strouse, J. J., Wilson, R., Beach, M. C., Haywood, C., Park, H., Witkop, C., Bass, E. B., & Segal, J. B. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-12-200806170-00221 · Cited by 287
Circumstances of death in adult sickle cell disease patients
Darbari, D. S., Kple-Faget, P., Kwagyan, J., Rana, S., Gordeuk, V. R., & Castro, O. (2006) · American Journal of Hematology · doi:10.1002/ajh.20685 · Cited by 276
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Fonseca, G. H. H., Souza, R., Salemi, V. M. C., Jardim, C. V. P., & Gualandro, S. F. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00134410 · Cited by 274
Brawley, O. W., Cornelius, L. J., Edwards, L. R., Gamble, V. N., Green, B. L., Inturrisi, C., James, A. H., Laraque, D., Mendez, M., Montoya, C. J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-12-200806170-00220 · Cited by 272
Anthi, A., Machado, R. F., Jison, M. L., Taveira-DaSilva, A. M., Rubin, L. J., Hunter, L., Hunter, C. J., Coles, W., Nichols, J., Avila, N. A., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1498oc · Cited by 270
Self-citationMachado, R. F., Barst, R. J., Yovetich, N. A., Hassell, K. L., Kato, G. J., Gordeuk, V. R., Gibbs, J. S. R., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Blood · doi:10.1182/blood-2010-09-306167 · Cited by 250
Self-citationDe Castro, L. M., Jonassaint, J. C., Graham, F. L., Ashley‐Koch, A., & Telen, M. J. (2008) · American Journal of Hematology · doi:10.1002/ajh.21058 · Cited by 243
Reperfusion injury pathophysiology in sickle transgenic mice
Osarogiagbon, U. R., Choong, S., Belcher, J. D., Vercellotti, G. M., Paller, M. S., & Hebbel, R. P. (2000) · Blood · doi:10.1182/blood.v96.1.314 · Cited by 233
Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension
Mehari, A., Gladwin, M. T., Tian, X., Machado, R. F., & Kato, G. J. (2012) · JAMA · doi:10.1001/jama.2012.358 · Cited by 229
Self-citationCardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
Fitzhugh, C. D., Lauder, N., Jonassaint, J. C., Telen, M. J., Zhao, X., Wright, E. C., Gilliam, F. R., & De Castro, L. M. (2010) · American Journal of Hematology · doi:10.1002/ajh.21569 · Cited by 224
Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension
Archer, S. L., & Michelakis, E. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmct0904473 · Cited by 224
Hemolysis-associated priapism in sickle cell disease
Nolan, V. G., Wyszynski, D. F., Farrer, L. A., & Steinberg, M. H. (2005) · Blood · doi:10.1182/blood-2005-04-1594 · Cited by 215
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
Machado, R. F., Martyr, S., Kato, G. J., Barst, R. J., Anthi, A., Robinson, M. R., Hunter, L., Coles, W., Nichols, J., Hunter, C., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05625.x · Cited by 212
Self-citationPulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases
Haque, A. K., Gokhale, S., Rampy, B. A., Adegboyega, P., Duarte, A., & Saldana, M. J. (2002) · Human Pathology · doi:10.1053/hupa.2002.128059 · Cited by 202
Pulmonary hypertension and nitric oxide depletion in sickle cell disease
Bunn, H. F., Nathan, D. G., Dover, G. J., Hebbel, R. P., Platt, O. S., Rosse, W. F., & Ware, R. E. (2010) · Blood · doi:10.1182/blood-2010-02-268193 · Cited by 202
N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
Machado, R. F., Anthi, A., Steinberg, M. H., Bonds, D., Sachdev, V., Kato, G. J., Taveira-DaSilva, A. M., Ballas, S. K., Blackwelder, W., Xu, X., et al. (2006) · JAMA · doi:10.1001/jama.296.3.310 · Cited by 197
Self-citationMinniti, C. P., Sable, C., Campbell, A., Rana, S., Ensing, G., Dham, N., Onyekwere, O., Nouraie, M., Kato, G. J., Gladwin, M. T., et al. (2009) · Haematologica · doi:10.3324/haematol.13812 · Cited by 186
Self-citationSickle Cell Anaemia: Progress in Pathogenesis and Treatment
Ballas, S. K. (2002) · Drugs · doi:10.2165/00003495-200262080-00003 · Cited by 181
Nolan, V. G., Adewoye, A., Baldwin, C., Wang, L., Ma, Q., Wyszynski, D. F., Farrell, J. J., Sebastiani, P., Farrer, L. A., & Steinberg, M. H. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06074.x · Cited by 172
Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease
Mekontso Dessap, A., Leon, R., Habibi, A., Nzouakou, R., Roudot-Thoraval, F., Adnot, S., Godeau, B., Galacteros, F., Brun-Buisson, C., Brochard, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1606oc · Cited by 170
Hebbel, R. P. (2011) · American Journal of Hematology · doi:10.1002/ajh.21952 · Cited by 169
Gordeuk, V. R., Sachdev, V., Taylor, J. G., Gladwin, M. T., Kato, G. J., & Castro, O. L. (2007) · American Journal of Hematology · doi:10.1002/ajh.21016 · Cited by 149
Self-citationThe Heart in Sickle Cell Anemia
Covitz, W., Espeland, M. A., Gallagher, D. M., Hellenbrand, W. E., Leff, S., & Talner, N. S. (1995) · CHEST Journal · doi:10.1378/chest.108.5.1214 · Cited by 147
Sachdev, V., Kato, G. J., Gibbs, J. S. R., Barst, R. J., Machado, R. F., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.032920 · Cited by 147
Self-citationBarst, R. J., Mubarak, K. K., Machado, R. F., Ataga, K. I., Benza, R. L., Castro, O. L., Naeije, R., Sood, N., Swerdlow, P. S., Hildesheim, M. E., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08097.x · Cited by 136
Self-citationComparisons of High Versus Low Emergency Department Utilizers in Sickle Cell Disease
Aisiku, I. P., Smith, W. R., McClish, D. K., Levenson, J. L., Penberthy, L. T., Roseff, S. D., Bovbjerg, V. E., & Roberts, J. D. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.07.050 · Cited by 135
Myoglobin as a model system for designing heme protein based blood substitutes
Dou, Y., Maillett, D. H., Eich, R. F., & Olson, J. S. (2002) · Biophysical Chemistry · doi:10.1016/s0301-4622(02)00090-x · Cited by 130
Machado, R. F., Mack, A. K., Martyr, S. E., Barnett, C. F., MacArthur, P. H., Sachdev, V., Ernst, I., Hunter, L. A., Coles, W. A., Nichols, J., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06417.x · Cited by 127
Self-citationCardiac Abnormalities in Children With Sickle Cell Anemia
Lester, L. A., Sodt, P. C., Hutcheon, N., & Arcilla, R. A. (1990) · CHEST Journal · doi:10.1378/chest.98.5.1169 · Cited by 122
Cardiopulmonary Complications of Sickle Cell Disease: Role of Nitric Oxide and Hemolytic Anemia
Gladwin, M. T., & Kato, G. J. (2005) · Hematology · doi:10.1182/asheducation-2005.1.51 · Cited by 116
Self-citationSickle Cell Lung Disease and Sudden Death
Graham, J. K., Mošunjac, M., Hanzlick, R. L., & Mosunjac, M. I. (2007) · American Journal of Forensic Medicine & Pathology · doi:10.1097/01.paf.0000257397.92466.50 · Cited by 107
Johnson, M. C., Kirkham, F. J., Redline, S. S., ROSEN, C. L., Yan, Y., Roberts, I. A. G., Gruenwald, J., Marek, J., & DeBaun, M. R. (2010) · Blood · doi:10.1182/blood-2009-06-227447 · Cited by 101
Pulmonary Hypertension in Children and Adolescents with Sickle Cell Disease
Onyekwere, O. C., Campbell, A., Teshome, M., Onyeagoro, S., Sylvan, C., Akintilo, A., Hutchinson, S. K., Ensing, G. J., Gaskin, P. R. A., Kato, G. J., et al. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9018-x · Cited by 99
Cardiac abnormalities in children with sickle cell anemia
Batra, A. S., Acherman, R. J., Wong, W., Wood, J. C., Chan, L. S., Ramicone, E., Ebrahimi, M., & Wong, P. C. (2002) · American Journal of Hematology · doi:10.1002/ajh.10154 · Cited by 95
Evaluation of left ventricular function in patients with sickle cell anemia
Gerry, J. L., Baird, M. G., & Fortuin, N. J. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90568-4 · Cited by 94
Cardiac function in sickle cell anemia
Denenberg, B. S., Criner, G. J., Jones, R. A., & Spann, J. F. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90208-4 · Cited by 90
High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension
Sundaram, N., Tailor, A., Mendelsohn, L. G., Wansapura, J. P., Wang, X., Higashimoto, T., Pauciulo, M. W., Gottliebson, W. M., Kalra, V. K., Nichols, W. C., et al. (2010) · Blood · doi:10.1182/blood-2009-09-244830 · Cited by 89
Cardiopulmonary Responses to Exercise in Women with Sickle Cell Anemia
Callahan, L. A., Woods, K. F., Mensah, G. A., Ramsey, L. T., Barbeau, P., & Gutin, B. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2002036 · Cited by 87
Minniti, C. P., Machado, R. F., Coles, W. A., Sachdev, V., Gladwin, M. T., & Kato, G. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07906.x · Cited by 81
Self-citationCaldas, M. M. C., Meira, Z. M. A., & Barbosa, M. M. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.06.001 · Cited by 68
Machado, R. F., Hildesheim, M. E., Mendelsohn, L. G., Remaley, A. T., Kato, G. J., & Gladwin, M. T. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08777.x · Cited by 66
Self-citationPulmonary hypertension and NO in sickle cell
Gladwin, M. T., Barst, R. J., Castro, O. L., Gordeuk, V. R., Hillery, C. A., Kato, G. J., Kim‐Shapiro, D. B., Machado, R. F., Morris, C. R., Steinberg, M. H., et al. (2010) · Blood · doi:10.1182/blood-2010-04-282095 · Cited by 66
Self-citationMyocardial ischaemia in children with sickle cell disease
de Montalembert, M. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.027326 · Cited by 65
Dham, N., Ensing, G. J., Minniti, C. P., Campbell, A., Arteta, M., RANA, S. R., Darbari, D. S., Nouraie, M. S., Onyekwere, O. C., Lasota, M., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.034 · Cited by 63
Self-citationHankins, J. S., McCarville, M. B., Hillenbrand, C. M., Loeffler, R. B., Ware, R. E., Song, R., Smeltzer, M. P., & Joshi, V. M. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22587 · Cited by 59
Lamers, L. J., Ensing, G. J., Pignatelli, R. H., Goldberg, C. S., Bezold, L. I., Ayres, N. A., & Gajarski, R. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.005 · Cited by 52
Left ventricular filling in sickle cell anemia
Balfour, I. C., Covitz, W., Arensman, F. W., et al. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90952-6 · Cited by 50
Inati, A. C., Musallam, K. M., Wood, J. C., Sheikh‐Taha, M., Daou, L., & Taher, A. T. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01345.x · Cited by 37
Prolonged QTc interval in children and young adults with sickle cell disease at steady state
Liem, R. I., Young, L., & Thompson, A. A. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21973 · Cited by 36
Continuous electrocardiographic monitoring in patients with sickle‐cell anemia during pain crisis
Maisel, A. S., Friedman, H. S., Flint, L., Koshy, M., & Prabhu, R. (1983) · Clinical Cardiology · doi:10.1002/clc.4960060707 · Cited by 36
Myocardial infarction in sickle-cell disease
Pavlů, J., Ahmed, R. E., O’Regan, D. P., Partridge, J., Lefroy, D. C., & Layton, D. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60114-7 · Cited by 34
Acute Myocardial Infarction in Sickle Cell Disease: A Systematic Review
Pannu, R., Zhang, J., Andraws, R., Armani, A. M., Patel, P., & Mancusi-Ungaro, P. (2008) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e3181668ac3 · Cited by 33
Sickle cell anemia: does myocardial ischemia occur during crisis?
Norris, S. L., Johnson, C. S., & Haywood, L. J. (1991) · PubMed · Cited by 32
Myocardial ischaemia in sickle cell anaemia: evaluation using a new scoring system
Bode-Thomas, F., Hyacinth, H. I., Ogunkunle, O. O., & Omotoso, A. B. (2011) · Annals of Tropical Paediatrics · doi:10.1179/1465328110y.0000000006 · Cited by 27
Echocardiographic findings in patients with sickle cell disease
Naoman, S. G., Nouraie, M. S., Castro, O. L., Nwokolo, C., Fadojutimi-Akinsiku, M., Diaz, S. F., Willie-Carnegie, G., Andrews, N., & Gordeuk, V. R. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0764-0 · Cited by 25
Deymann, A. J., & Goertz, K. K. (2003) · PEDIATRICS · doi:10.1542/peds.111.2.e183 · Cited by 23
Sudden Death in Sickle Cell Disease
Liesner, R. J., & Vandenberghe, E. (1993) · Journal of the Royal Society of Medicine · doi:10.1177/014107689308600822 · Cited by 18
Complications pulmonaires des syndromes drépanocytaires majeurs chez l’adulte
Maître, B., Dessap, A. M., Habibi, A., Bachir, D., Parent, F., Godeau, B., & Galactéros, F. (2011) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.08.013 · Cited by 18
Dang, N. C., Johnson, C., Eslami‐Farsani, M., & Haywood, L. J. (2005) · American Journal of Hematology · doi:10.1002/ajh.20385 · Cited by 16
Transient Left Ventricular Dysfunction in Childhood Sickle Cell Disease
Johnson, W. H., McCrary, R. B., & Mankad, V. N. (1999) · Pediatric Cardiology · doi:10.1007/s002469900447 · Cited by 11
Machado, R. F., Hildesheim, M. E., Mendelsohn, L. G., Kato, G. J., & Gladwin, M. T. (2009) · Blood · doi:10.1182/blood.v114.22.1541.1541 · Cited by 5
Self-citation
Research works printed but not linked: 6
- Maitre, 2011, Pulmonary complications in adult sickle cell disease, Rev Mal Respir, 28, 129
- Brock, 2009, Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction, Urology, 73, 756, 10.1016/j.urology.2008.10.058 · doi:10.1016/j.urology.2008.10.058
- Sachdev, 2011, Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom, Circulation, 124, 1452, 10.1161/CIRCULATIONAHA.111.032920 · DOI · Paper page
- Hannoush, 2011, A lower tissue Doppler E/Ea threshold predicts elevated pulmonary capillary wedge pressure in sickle cell patients (abstr), J Am Soc Echocardiogr, 24, B18
- Willens, 1983, A noninvasive comparison of left ventricular performance in sickle cell anemia and chronic aortic regurgitation, Clin Cardiol, 6, 542, 10.1002/clc.4960061105 · doi:10.1002/clc.4960061105
- Mueller, 2006, Prolonged QT interval in pediatric sickle cell disease, Pediatr Blood Cancer, 47, 831, 10.1002/pbc.20539 · doi:10.1002/pbc.20539
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Self-citationCardiovascular complications and risk of death in sickle-cell disease
Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164
Self-citationHaematological determinants of cardiac involvement in adults with sickle cell disease
Damy, T., Bodez, D., Habibi, A., Guellich, A., Rappeneau, S., Inamo, J., Guendouz, S., Gellen-Dautremer, J., Pissard, S., Loric, S., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv555 · Cited by 65
Caughey, M. C., Poole, C., Ataga, K. I., & Hinderliter, A. L. (2015) · British Journal of Haematology · doi:10.1111/bjh.13447 · Cited by 41
Metadata
- Authors
- Gladwin, M. T., & Sachdev, V.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 59
- Issue
- 13
- Pages
- 1123-1133
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2033357297
- Cited by
- 276
- References
- 102
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 539 d)
- Funders
- NIH (R01HL098032, RO1HL096973, PO1HL103455)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.